AbCellera Biologics Inc.

UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC ABCL

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/13/2026

Shares

7,876,629

Value ($000)

26,938

Weight

0.0%

2022 Q2 - 2025 Q4 (7 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/13/2026	26,938	0.0%	7,876,629	12/31/2025
2025 Q2	8/14/2025	29,058	0.0%	8,471,619	6/30/2025
2025 Q1	5/19/2025	34,946	0.0%	15,671,063	3/31/2025
2024 Q4	2/14/2025	13,185	0.0%	4,500,000	12/31/2024
2024 Q3	11/14/2024	11,934	0.0%	4,590,103	9/30/2024
2024 Q2	8/14/2024	13,612	0.0%	4,598,626	6/30/2024
2022 Q2	8/12/2022	341	0.0%	31,998	6/30/2022